- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Article 4(b)
Column 1 | CIRCUMSTANCES EXCLUDING MEDICINAL PRODUCTS FROM THE CLASS OF PRESCRIPTION ONLY MEDICINES | ||
---|---|---|---|
Column 2 | Column 3 | Column 4 | |
Substances | Maximum Strength | Use, Pharmaceutical form or route of administration | Maximum dose and maximum daily dose |
Pseudoephedrine Hydrochloride | Internal | (a)In the case of a controlled release preparation:
(b)in any other case:
| |
Tioconazole | (1) 2.0 per cent. | (1) External (except vaginal use) (2) External vaginal use for treatment of vaginal candidiasis |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: